The company announced that it has received regulatory approval for two surface cleaners from the Australian Therapeutics Goods Association. This follows the acquisition of its Australian distributor's business in July, thereby broadening its product offering to include Tristel Fuse and Tristel Jet. We have made minor changes to forecasts, raising EPS by 1.8% to 3.59p for FY 2017. We are raising our target price to 140p to reflect these changes and likely acceleration of growth in FY 2018. At ....